Maurizio Aricò
OncoEmatologia Pediatrica
Ospedale dei Bambini "G. Di Cristina"
90100 Palermo
Italy
Name/email consistency: high
- Langerhans cell histiocytosis: too many cytokines, not enough gene regulation?. Aricò, M. Pediatr. Blood. Cancer (2006)
- The seventh international childhood acute lymphoblastic leukemia workshop report: Palermo, Italy, January 29--30, 2005. Aricó, M., Baruchel, A., Bertrand, Y., Biondi, A., Conter, V., Eden, T., Gadner, H., Gaynon, P., Horibe, K., Hunger, S.P., Janka-Schaub, G., Masera, G., Nachman, J., Pieters, R., Schrappe, M., Schmiegelow, K., Valsecchi, M.G., Pui, C.H. Leukemia (2005)
- Treatment reduction in highly selected standard-risk childhood acute lymphoblastic leukemia. The AIEOP ALL-9501 study. Aricò, M., Conter, V., Valsecchi, M.G., Rizzari, C., Boccalatte, M.F., Barisone, E., Messina, C., De Rossi, G., Lo Nigro, L., Pession, A., Locatelli, F., Micalizzi, C., Basso, G. Haematologica (2005)
- Langerhans cell histiocytosis in adults: more questions than answers?. Aricò, M. Eur. J. Cancer (2004)
- Histiocytic disorders. Aricò, M., Clementi, R., Caselli, D., Danesino, C. Hematol. J. (2003)
- Osteonecrosis: An emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia. Aricò, M., Boccalatte, M.F., Silvestri, D., Barisone, E., Messina, C., Chiesa, R., Santoro, N., Tamaro, P., Lippi, A., Gallisai, D., Basso, G., De Rossi, G. Haematologica (2003)
- Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society. Aricò, M., Girschikofsky, M., Généreau, T., Klersy, C., McClain, K., Grois, N., Emile, J.F., Lukina, E., De Juli, E., Danesino, C. Eur. J. Cancer (2003)
- Late relapse of childhood acute lymphoblastic leukemia and pcr-monitoring of minimal residual disease: how much time can elapse between "molecular" and clinical relapse?. Aricò, M., Germano, G., del Giudice, L., Ziino, O., Locatelli, F., Basso, G. Haematologica (2002)
- Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Berlin-Frankfurt-Muenster protocol II. Aricò, M., Valsecchi, M.G., Conter, V., Rizzari, C., Pession, A., Messina, C., Barisone, E., Poggi, V., De Rossi, G., Locatelli, F., Micalizzi, M.C., Basso, G., Masera, G. Blood (2002)